Close

Analyst Ratings for Champions Oncology (CSBR) [Neutrals]

CSBR Rating Summary

CSBR Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CSBR
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $8.25 (+46%) * Over Last 12-Mos
Rating Score: 6.7 / 10   Percentile Rank: 72%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/16/2023 Benchmark Robert Wasserman Downgrade Hold
(Buy)
N/A
(N/A)
4.10
(5.65)
37.8% Details
7/24/2019 Janney Paul Knight Downgrade Neutral
(Buy)
N/A
(N/A)
7.21
(5.65)
-21.64% Details